Cent Eur J Public Health 2018, 26(1):49-53 | DOI: 10.21101/cejph.a4637

The efficacy of selected bariatric surgery methods on lipid and glucose metabolism: a retrospective 12-month study

Marek Bužga1, Petra Marešová1,2, Karin Petřeková1, Pavol Holéczy1, Kamil Kuča2,3
1 Research Obesity Centre, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
2 Faculty of Informatics and Management, University of Hradec Králové, Hradec Králové, Czech Republic
3 University Hospital Hradec Králové, Biomedical Research Centre, Hradec Králové, Czech Republic

Objective: Approximately 25% of the Czech population is currently obese. Obesity rates are expected to increase in the future. Obesity not only raises the risk of health complications for individuals, but increasing rates also represent a significant and steadily growing economic burden for healthcare systems and society as a whole. The aim of this study was to evaluate the therapeutic efficacy of three methods of bariatric surgery: laparoscopic greater curve plication (LGCP), laparoscopic sleeve gastrectomy (LSG), and Roux-en-Y gastric bypass (RYBG) in patients with type 2 diabetes mellitus (DM). This study examined the influence of bariatric surgery on body weight and BMI, changes in serum glucose and markers of lipid metabolism.

Methods: This study evaluated outcomes in 74 patients with type 2 DM who underwent LGCP, LSG or RYGB. Patient selection followed guidelines of the International Federation for the Surgery of Obesity, i.e. BMI ≥ 40 kg/m2 or BMI ≥ 35 kg/m2 with associated comorbidities or BMI < 35 kg/m2. For each of the procedures, the hypotheses were tested with the Bonferroni method.

Results: Statistically significant weight loss, 20.2 ± 9.3 kg on average, occurred by 12 months after surgery, with maximum weight reduction of 38 kg. Over the 12-month period, average fasting glycaemia decreased by 2.58 mmol/L after LGCP, by 2.01 mmol/L after LSG, and by 4.64 mmol/L after RYGB. Triacylglycerol (TGC) values decreased significantly with all procedures. The mean decrease was 1.35 mmol/L after LGCP and 1.06 mmol/L after LSG. The greatest TGC concentration decrease, 1.92 mmol/L, occurred after RYGB. Average concentrations decreased below 1.7 mmol/L. There was a statistically significant difference in body weight and BMI reduction between LGCP and LSG groups, as well as between LGCP and RYGB groups. A significant difference in the glucose decrease was observed between the LSG and RYGB groups, which can be explained by the fact that glycaemia and HbA1c levels were different between these groups prior to surgery.

Conclusions: The best results from the carbohydrate metabolism point reached the malabsorption method RYGB. However, the other two restrictive methods also achieved very good results. In particular, the LGCP method has not only the effect on weight reduction but also on metabolic functions and consequently points to potential healthcare expenditure savings.

Keywords: bariatric surgery, case study, Czech Republic, LGCP, LSG, RYGB outcomes

Received: November 22, 2015; Revised: February 7, 2018; Published: March 30, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bužga M, Marešová P, Petřeková K, Holéczy P, Kuča K. The efficacy of selected bariatric surgery methods on lipid and glucose metabolism: a retrospective 12-month study. Cent Eur J Public Health. 2018;26(1):49-53. doi: 10.21101/cejph.a4637. PubMed PMID: 29684298.
Download citation

References

  1. Finkelstein EA, DiBonaventura Md, Burgess SM, Hale BC. The costs of obesity in the workplace. J Occup Environ Med. 2010 Oct;52(10):971-6. Go to original source... Go to PubMed...
  2. Matoulek M, Svačina Š, Lajka, J. The incidence of obesity and its complications in the Czech Republic. Vnitr Lek. 2010;56(10):1019-27. (In Czech.) Go to PubMed...
  3. Nguyen NT, Magno CP, Lane KT, Hinojosa MW, Lane JS. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J Am Coll Surg. 2008 Dec;207(6):928-34. Go to PubMed...
  4. Sullivan PW, Ghushchyan VH, Ben-Joseph R. The impact of obesity on diabetes, hyperlipidemia and hypertension in the United States. Qual Life Res. 2008 Oct;17(8):1063-71. Go to original source... Go to PubMed...
  5. Ackroyd R, Mouiel J, Chevallier JM, Daoud F. Cost-effectiveness and budget impact of obesity surgery in patients with type-2 diabetes in three European countries. Obes Surg. 2006 Nov;16(11):1488-503. Go to original source... Go to PubMed...
  6. Franz MJ, VanWormer JJ, Crain AL, Boucher JL, Histon T, Caplan W, et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc. 2007 Oct;107(10):1755-67. Go to original source... Go to PubMed...
  7. Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013 Oct 22;347:f5934. Go to original source... Go to PubMed...
  8. Buchwald, H. The evolution of metabolic/bariatric surgery. Obes Surg. 2014 Aug;24(8):1126-35. Go to original source... Go to PubMed...
  9. Sjöström L, Peltonen M, Jacobson P, Ahlin S, Andersson-Assarsson J, Anveden Å, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014 Jun 11;311(22):2297-304. Go to original source... Go to PubMed...
  10. Anděl J. Fundamentals of mathematical statistics. Prague: Matfyzpress; 2005. (In Czech.)
  11. Czech Diabetes Society. Recommended process of care for type 2 diabetes mellitus. [Internet]. Prague: ČLS J.E.Purkyně; 2012 [cited 2015 Jun 20]. Available from: http://www.diab.cz/dokumenty/dm2_12.pdf. (In Czech.)
  12. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004 Oct 13;292(14):1724-37. Go to original source... Go to PubMed...
  13. Peterli R, Steinert RE, Woelnerhanssen B, Peters T, Christoffel-Courtin C, Gass M, et al. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg. 2012 May;22(5):740-8. Go to original source... Go to PubMed...
  14. Vanguri P, Brengman M, Oiticica C, Wickham EP 3rd, Bean MK, Lanning DA. Laparoscopic gastric plication in the morbidly obese adolescent patient. Semin Pediatr Surg. 2014 Feb;23(1):24-30. Go to original source... Go to PubMed...
  15. Bradnova O, Kyrou I, Hainer V, Vcelak J, Halkova T, Sramkova P, et al. Laparoscopic greater curvature plication in morbidly obese women with type 2 diabetes: effects on glucose homeostasis, postprandial triglyceridemia and selected gut hormones. Obes Surg. 2014 May;24(5):718-26. Go to original source... Go to PubMed...
  16. de Aquino LA, Pereira SE, de Souza Silva J, Sobrinho CJ, Ramalho A. Bariatric surgery: impact on body composition after Roux-en-Y gastric bypass. Obes Surg. 2012 Feb;22(2):195-200. Go to original source... Go to PubMed...
  17. Shah N, Greenberg JA, Leverson G, Statz AK, Jolles SA, Funk LM. Weight loss after bariatric surgery: a propensity score analysis. J Surg Res. 2016 May 15;202(2):449-54. Go to original source... Go to PubMed...
  18. Bužga M, Marešová P, Seidlerová A, Zonča P, Holéczy P, Kuča K. The influence of methods of bariatric surgery for treatment of type 2 diabetes mellitus. Ther Clin Risk Manag. 2016 Apr 15;12:599-605. Go to original source... Go to PubMed...
  19. Zhang F, Strain GW, Lei W, Dakin GF, Gagner M, Pomp A. Changes in lipid profiles in morbidly obese patients after laparoscopic sleeve gastrectomy (LSG). Obes Surg. 2011 Mar;21(3):305-9. Go to original source... Go to PubMed...
  20. Vidal J, Ibarzabal A, Romero F, Delgado S, Momblán D, Flores L, et al. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg. 2008 Sep;18(9):1077-82. Go to original source... Go to PubMed...
  21. Abbatini F, Rizzello M, Casella G, Alessandri G, Capoccia D, Leonetti F, et al. Long term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on Type 2 diabetes. Surg Endosc. 2010 May;24(5):1005-10. Go to original source... Go to PubMed...
  22. Lee WJ, Chong K, Ser KH, Lee YC, Chen SC, Chen JC, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011 Feb;146(2):143-8. Go to original source... Go to PubMed...
  23. Bužga M, Švagera Z, Tomášková H, Hauptman K, Holéczy P. Metabolic effects of sleeve gastrectomy and laparoscopic greater curvature plication: an 18-month prospective, observational, open-label study. Obes Surg. 2017 Dec;27(12):3258-66. Go to original source... Go to PubMed...
  24. Gaur A, Naidu CS, Rao PP, Sharma S, Singh AK, Trehan V, et al. The effect of laparoscopic sleeve gastrectomy (LSG) on glycemic control in morbidly obese patients. Int J Surg. 2016 Apr;28:131-5. Go to original source... Go to PubMed...
  25. Slater BJ, Bellatorre N, Eisenberg D. Early postoperative outcomes and medication cost savings after laparoscopic sleeve gastrectomy in morbidly obese patients with type 2 diabetes. J Obes. 2011;2011:350523. Go to original source... Go to PubMed...
  26. Fried M, Dolezalova K, Buchwald JN, McGlennon TW, Sramkova P, Ribaric G. Laparoscopic greater curvature plication (LGCP) for treatment of morbid obesity in a series of 244 patients. Obes Surg. 2012 Aug;22(8):1298-307. Go to original source... Go to PubMed...
  27. Bužga M, Holéczy P, Švagera Z, Zonča P. Laparoscopic gastric plication and its effect on saccharide and lipid metabolism: a 12-month prospective study. Wideochir Inne Tech Maloinwazyjne. 2015 Sep;10(3):398-405. Go to original source... Go to PubMed...